Cytek Biosciences (CTKB) Raw Materials (2020 - 2026)

Cytek Biosciences' Raw Materials history runs 7 years deep, the most recent figure standing at $23.6 million for Q1 2026.

• Quarterly Raw Materials changed 0.4% year-over-year to $23.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.6 million (changed 0.4% YoY) and the FY2025 annual result came in at $20.4 million, down 9.43% from the prior year.
• Raw Materials was $23.6 million for Q1 2026 at Cytek Biosciences, up from $20.4 million in the prior quarter.
• Across five years, Raw Materials topped out at $42.2 million in Q1 2023 and bottomed at $20.4 million in Q4 2025.
• A 5-year average of $28.7 million and a median of $26.8 million in 2024 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2023 — Raw Materials soared 99.18% — and 2024, when it slumped 36.81%.
• Cytek Biosciences' Raw Materials stood at $26.9 million in 2022, then soared by 32.66% to $35.7 million in 2023, then slumped by 36.81% to $22.6 million in 2024, then fell by 9.43% to $20.4 million in 2025, then rose by 15.65% to $23.6 million in 2026.
• Business Quant data shows CTKB's Raw Materials at $23.6 million in Q1 2026, $20.4 million in Q4 2025, and $24.7 million in Q3 2025.